Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review

Immune checkpoint inhibitors tremendously improve cancer prognosis; however, severe-grade immune-related adverse events may cause premature death. Current recommendations for checkpoint inhibitor-related pneumonitis (CIP) treatment are mainly about immunosuppressive therapy, and anti-fibrotic agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Lei, Meng, Fanqi, Wang, Wei, Wang, Xu-hao, Shen, Hui, Bao, Pengchen, Kang, Jian, Kong, Delei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872202/
https://www.ncbi.nlm.nih.gov/pubmed/36703957
http://dx.doi.org/10.3389/fimmu.2022.1072612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872202/
https://www.ncbi.nlm.nih.gov/pubmed/36703957
http://dx.doi.org/10.3389/fimmu.2022.1072612

Ejemplares similares